INOVIQ Ltd (ASX:IIQ) CEO Leearne Hinch speaks with Proactive at the ASX Small and Mid Cap Conference - September 2023. The company is developing and commercialising next-generation exosome solutions and precision diagnostics to improve the diagnosis and treatment of cancer and other diseases. IIQ has commercialised the EXO-NET pan-exosome capture tool for research purposes and the hTERT test for bladder cancer. The company’s cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast and other cancers.
INOVIQ with Proactive at ASX Small and Mid Cap Conference
